The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

President and Chief Executive Officer — Bryan C. Hanson Chief Financial Officer — Wayde D. McMillan Head of Investor Relations — Amy Wakeham Management stated the company is actively evaluating ...

Solventum has a few good businesses, but the market is treating it as a complicated company. Its main parts are MedSurg, Dental, HIS, and a smaller Water / All Other. The thesis says the stock looks ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

In the latest quarter, 5 analysts provided ratings for Solventum (NYSE:SOLV), showcasing a mix of bullish and bearish perspectives. The following table summarizes their recent ratings, shedding light ...

*Data in the schedule above is intentionally rounded to the nearest million and, therefore, may not sum. (a) 2025 restructuring costs primarily related to the Company's Transform for the Future ...

Investing.com - KeyBanc upgraded Solventum (NYSE:SOLV) from Sector Weight to Overweight with a price target of $97.00, citing the company’s encouraging start since its spin-off from 3M. Currently ...

2024年4月、工業用素材・事務用品大手「3M」から分離上場したグローバルヘルスケア企業。 材料科学やデータサイエンスなどを活用した広範な製品ポートフォリオを開発、製造、商品化している。主力の「メドサーグ（医療ソリューション）」事業では ...

Solventum beat estimated earnings by 4.67%, reporting an EPS of $1.57 versus an estimate of $1.5. Revenue was down $76.00 million from the same period last year. The company beat on EPS by $0.07 in ...